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Summary 
Self-proteins are regularly processed for presentation to autoreactive T  cells in association with 
both class I and class II major histocompatibility complex (MHC) molecules. The presentation 
of self-peptides plays a crucial role in the acquisition of T  cell repertoire during thymic selec- 
tion. We previously reported that the self-MHC class I peptide L  a 61-80 was immunogenic in 
syngeneic B10.A mice (H-2~).  We showed that despite its high affinity for self-MHC class II 
molecules, L  a 61-80 peptide failed to induce elimination of autoreactive CD4 + T  cells, pre- 
sumably due  to  incomplete processing and presentation  in  the  B10.A's  developing thymus 
(cryptic-selfpeptide). In this report, we showed that the cryptic phenotype was not an intrinsic 
property of the self-peptide L  a 61-80 since it was found to be naturally presented and subse- 
quently tolerogenic in BALB/c mice (H-2  a) (dominant self-peptide). In addition, the self-pep- 
tide L  a 61-80 was  found to be immunogenic in different H-2  a mice while it was invariably 
tolerogenic in H-2  a mice regardless  of their background genes.  We observed that L  a 61-80 
bound equally well to H-2  a and H-2  k MHC class II molecules. Also, no correlation was found 
between the quantity of self-L  a protein and the tolerogenicity ofL  a 61-80. Surprisingly, L  a 61- 
80 was not naturally presented in (H-2  a X H-2  a) F1 mice, indicating that the H-2  a MHC locus 
contained a gene that impaired the presentation of the self-peptide. Analyses ofT cell responses 
to the self-peptide in several H-2 recombinant mice revealed that the presentation ofL  a 61-80 
was  controlled by genes that mapped to a  170-kb portion of the MHC  class II region. This 
study shows that (a) endogenously processed self-peptides presented by MHC class II molecules 
are involved in shaping the CD4 + T  cell repertoire in the thymus;  (b) The selection of self- 
peptides for presentation by MHC  class II molecules to nascent autoreactive T  cells is influ- 
enced by nonstructural MHC genes that map to a 170-kb portion of the MHC class II region; 
and (c) the MHC locus of H-2  a mice encodes factors that prevent or abrogate the presentation 
by MHC class II molecules of the self-peptide L  a 61-80. These findings may have important 
implications for understanding the molecular mechanisms involved in T cell repertoire acquisi- 
tion and self-tolerance induction. 
p rocessed foreign antigens are presented to T  lympho- 
cytes in the form ofpeptides associated with self-MHC 
molecules at the surface of APCs (1, 2). There is a body of 
evidence  that  demonstrates  that  autologous  proteins  are 
also  regularly processed for presentation to self-reactive T 
cells in association with either class I or class II MHC mol- 
ecules (3,  4).  Furthermore, elution of the peptides bound 
to surface MHC molecules revealed that the vast majority 
of MHC peptide-binding grooves were filled with a vari- 
ety of protein fragments of self-origin (5, 6). The self-pep- 
tides presented in the thymus during ontogeny play a key 
role in shaping the T  cell repertoire. High affinity recogni- 
tion ofself-peptide/MHC complexes by developing T cells 
results  in their deletion/inactivation (negative selection) (7, 
8). Alternatively, T  cells engaged in low avidity interaction 
with self-peptides presented by self-MHC presumably sur- 
vive and undergo differentiation (positive selection; 9). The 
presentation  of self-peptides is  therefore an  essential  ele- 
ment in the establishment ofa T  cell repertoire. 
Dissection of the different antigen processing pathways is 
crucial for understanding the mechanisms that govern the 
selection of autologous peptides for presentation to self-re- 
active  T  cells.  It  has  become  clear  that  determining  the 
ability ofpeptides to bind to self-MHC molecules is neces- 
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Volume 182  November 1995 1481-1491 sary  but  not  sufficient  to  predict  their  presentation  by 
APCs. The set ofpeptides selected for display also depends 
on other factors, including the enzymatic machinery of the 
APC, the route of antigen processing,  and the presence of 
several  protein  cofactors.  Among  them,  the  MHC-en- 
coded proteasome  subunits,  LMP-2  and-7  (10,  11),  and 
the transporter proteins,  TAP-1 and -2 (12-14) are known 
to be specific participants  in the processing of endogenous 
cytosolic proteins and their presentation in peptide form by 
MHC  class  I molecules.  Similarly,  the invariant chain  (Ii) 1 
(15),  heat  shock proteins  (16),  and  the  recently described 
Ma and Mb gene products (17,  18)  are specific cofactors in 
the  presentation  of exogenous  foreign proteins  by MHC 
class II molecules. The endogenous (class I) and exogenous 
(class  II)  antigen-processing  pathways  have  always  been 
considered  distinct.  However,  considerable  evidence  sug- 
gesting  that  there  is  cross-talk  between  the  two  antigen 
processing pathways has recently been provided. Thus, en- 
dogenously synthesized proteins can also represent a source 
ofpeptides for class II presentation (19, 20). Supporting this 
view,  a large variety of peptides eluted from MHC  class II 
molecules has been found to be derived from endogenous 
self-proteins  (6).  Therefore,  examination  of the  mecha- 
nisms underlying the MHC  class II endogenous processing 
pathway may provide insight into the principals  of thymic 
selection ofCD4 + T  cells. 
We  and  others  reported  that  certain  self-peptides  were 
immunogenic in syngeneic animals  (21,  22).  Using mouse 
self-MHC  class  I  protein  as  a  model  antigen,  we  showed 
that  the  self-peptide  L d 61-80  elicited  the  proliferation  of 
CD4 +  class  II-restricted T  cells  in syngeneic B10.A mice 
(H-2a).  This  result  demonstrated  that  although  the  self- 
peptide  L d 61-80 bound with  high affinity to self-class  II 
restriction  elements,  it failed to reach the threshold of pre- 
sentation that ensures T  cell tolerance during development 
(21, 23) (cryptic self-peptide). Another recent study by Loss 
et  al.  indicated  that  BALB/c  (H-2  a)  APCs naturally  pro- 
cessed and presented  the  setf-peptide  L d 61-80 in vitro in 
association  with  MHC  class  I!  molecules  (24).  This 
prompted us  to  determine  whether,  in  contrast  to B10.A 
mice, continuous presentation  of the self-peptide L a 61-80 
in BALB/c mice had occurred in vivo during thymic selec- 
tion and had indeed resulted in tolerance induction of the 
corresponding autoreactive T  cells  (dominant self-peptide). 
In this  article,  our  aim  was  to  identify  the  factors  that 
control  the  selection  of the  self-peptide  L  d 61-80  for  in 
vivo presentation  to T  cells.  To address  this  question,  we 
analyzed the class II-restricted presentation of the self-pep- 
tide  L a  61-80  to  CD4 +  autoreactive  T  cells  in  different 
mouse  strains.  We  first  showed  that  crypticity  or  domi- 
nance ofL  d 61-80 was not an intrinsic property of this self- 
peptide  since  L d 61-80 was found tolerogenic  (dominant) 
in  BALB/c  mice  while  it  was  immunogenic  (cryptic)  in 
B10.A mice.  Further immunogenetic analysis revealed that 
1Abbreviations used in this paper: din2, BALB/c-dm2; HEL, hen egg white 
lysozyme; Ii, invariant chain. 
the  self-peptide  L d  61-80  was  cryptic  in  different  H-2  a 
mice,  but  consistendy  dominant  in  mice  expressing  the 
H-2  a  MHC  haplotype,  regardless  of  their  background 
genes. To map the gene that controlled L d 61-80 presenta- 
tion,  we  compared  the  MHC  class  II presentation  of the 
self-peptide  in a panel of H-2 recombinant mouse strains. 
This led us to identify a  170-kb region of the MHC  locus 
that encodes a factor(s)  responsible for differential process- 
ing and presentation of the self-L  a peptide in MHC  class II 
context. 
Materials  and Methods 
Peptides.  The peptides  used in this study were synthesized  in 
the  Norris  Cancer  Center  Microchemistry  Laboratory  (USC) 
with  a  peptide  synthesizer  (model  430A;  Applied  Biosystems, 
Inc., Foster City, CA) using modified Merrifield  chemistry as de- 
scribed  (21). The amino acid sequence of the MHC class I-de- 
rived peptide  L  d 61-80 was  EtLITQIAKGQEQWFILVNLR,  T. 
The overlapping MHC  class I peptides  were  synthesized  using 
the pin synthesis technique. The procedure was modified as de- 
scribed  in  detail  elsewhere  (25) so  that  the  peptides  could be 
cleaved from the pins. 
Mice and Immunizations.  The  mice  used  in  this  study  were 
obtained from The Jackson Laboratory (Bar  Harbor,  ME)  and 
were housed at UCSF animal facilities. The mutant mouse strain 
BALB/c-dm2 (dm2) does not express the MHC class I L  d protein 
because  of a deletion of the relevant  3' flanking  region of the L  d 
gene. B10.GD mice that do not express E d class II MHC mole- 
cules were a generous gift from Dr. E. E. Sercarz  (University  of 
California  at Los Angeles,  Los Angeles,  CA). Mice of either sex 
were used at 3-8 mo of age. The mice were immunized in their 
hind  footpads with  20  p,g of the  MHC  peptide  emulsified  in 
complete CFA (Difco Laboratories,  Detroit, MI). 
Lymph Node and Spleen  T  Cell Proliferation Assays.  Popliteal 
lymph node and spleen cells were obtained 9-10 d after immuni- 
zation, and they were used in antigen-induced proliferation  as- 
says. Suspensions  of 5  X  10  s lymph node and  106  spleen  cells 
were prepared and washed in serum-free  HL-1  medium  (*Cen- 
trex, Portland, ME). The cells were then cultured in either 0.2 ml 
of ilL-1 medium containing 2 mM glutamine alone,  in the pres- 
ence  of the self-MHC  class I peptide  L  d 61-80 (50 ~g/ml),  or 
with a control peptide in 96-welt culture dishes for 4 d. Antigen- 
induced proliferation was assessed by determining the incorpora- 
tion of 1 /~Ci [3H]thymidine  during the last 18 h of culture. 
Immunofluorescence Analyses.  Splenocytes  and thymocytes from 
normal mice were collected and washed in Dulbecco's PBS con- 
taining 2% FCS and 0.1% sodium azide  (Sigma Immunochemi- 
cals, St.  Louis,  MO). The cells (2-5  ￿  105 cells per tube)  were 
then incubated for 30 rain on ice in the presence of  serial concen- 
trations  of  the  FITC-conjugated  anti-mouse  H-2Ld-reactive 
mAb,  30-5-7  (26).  In  all  experiments,  cells from  Ld-deficient 
BALB/c-dm2 (dm2) mice were used as a negative control. Non- 
specific  fluorescence  was  also measured using an irrelevant  iso- 
type-matched  FITC-conjugated  mouse  mAb  (IgG2a)  (Phar- 
Mingen, San Diego, CA). Fluorescence analyses were performed 
on viable nucleated cells using a FACSort  |  flow cytometer (Bec- 
ton Dickinson & Co., Mountain View, CA), and the data were 
displayed as mean channel fluorescence. 
T Cell Lines.  The CD4 + T  cell lines P69.2 (Ea-restricted,  L  d 
61-80-specific)  and B10.A-P11.2  (Ek-restricted,  L  a 61-80--spe- 
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tively.  Mice  were  immunized  in  their  hind  footpads with  the 
peptide  L  d  61-80  (20-50  I~g) emulsified  in  CFA.  9  d  later, 
pophteal lymph node cells were aseptically collected and cultured 
(5  X  10  6  cells/ml)  in  DME  (ICN,  Costa Mesa,  CA)  supple- 
mented with 2 mM glutamine,  2  ￿  10 -5 M  2-ME,  100 U/ml 
penicillin,  100 p,g/ml streptomycin, and 10% FCS (Gemini Bio- 
products, Inc., Calabasas, CA). T cell lines were stimulated  every 
other week with either antigen (peptide  at final concentration 20 
mM), syngeneic irradiated  splenocytes  (2 ￿  106 cells/ml)  as feed- 
ers, and 10 U/ml of human rlL-2 (Genzyme Corp., Cambridge, 
MA)  or IL-2 alone  (25 U/ml).  CD4  + phenotype of the T  cell 
lines  was  shown by two-color fluorescence analysis using anti- 
CD4-FITC (RM4-4) and anti-CD8-PE (53.6.7) mAb conjugates 
(PharMingen).  The prohferation of the T  cell line B10.A-P11.2 
to the peptide L  a 61-80 was found to be inhibited by anti-E k (17- 
3-3S),  but  not  anti-A  k (10.2.16)  mAb,  indicating  that  B10.A- 
Pll.2 recognizes this peptide in association with E k MHC class II 
molecules.  The  dm2-derived  T  cell  hne  P69.2  recognized the 
peptide  L  d 61-80 in the context of E d restriction  element since 
B10.GD splenocytes  (lacking E d) could not stimulate  the prohfer- 
ation of this cell hne in the presence of the specific peptide. For T 
cell line proliferation assays, rested  T  cells were placed into mi- 
crowells  (3-5  ￿  104 cells per well)  with  1-5  ￿  105  irradiated 
splenocytes  in the presence of the relevant peptide and incubated 
for 60  h.  Proliferation  was  measured  by the  incorporation  of 
[3H]thymidine (1 p,  Ci per well) during the last 12 h of culture. 
Competition  for MHC Binding.  1E1  T  hybridoma  cells that 
recognize the k repressor  peptide  12-26 in association  with I-E  d 
were used in MHC binding experiments  (105 cells per well).  T 
cells were cocultured for 24 h with the BALB/c-derived A20 B 
cell lymphoma (105 cells per well) used as APCs, in the presence 
of the relevant peptide (k rep 12-26,  10 ~M) and serial concen- 
trations  of the self-MHC class I peptide L  d 61-80. The hen egg 
white lysozyme (HEL)  105-120 peptide known for its binding to 
E a was used as a positive  control in the competition experiments. 
Each 96-well microplate was then centrifuged and 100 p,1 of each 
culture supematant transferred  to a new microtiter tray. IL-2 lev- 
els  in  culture  supematants  were  assessed by  monitoring  the 
[3H]thymidine incorporation of the  IL-2-dependent T  cell line 
CTLL-20. Briefly,  0.04 ml of each culture supematant was fur- 
ther incubated with 104 CTLL-20 cells for 24 h in a total volume 
of 0.2 ml HL-1 medium. Incorporation of I  p,  Ci [3H]thymidine 
was determined during the last 4 h of culture. Binding of the pep- 
tide L  a 61-80 to E k MHC class II molecules was performed as de- 
scribed earlier (27). 
Results 
The Cryptic Phenotype Is Not an Intrinsic Property of the Self- 
Peptide L d 61-80.  We  have  previously  shown  that  the 
self-MHC  class  I  peptide  L d 61-80 induced potent MHC 
class  II-restricted  T  cell  responses  in  syngeneic  B10.A 
mice.  This self-peptide  was cryptic in that despite  its high 
binding affinity for self-MHC class II molecules, it had not 
been  presented  efficiently  enough  to  ensure  tolerance  in 
the  developing  thymus  of B10.A  mice  (21).  Also,  recent 
work by Loss et al.  suggested that L d 61-80 was regularly 
presented in vitro at the surface ofBALB/c APCs in associ- 
ation with self-MHC class II molecules (24). Here, we ob- 
served that in contrast to B10.A mice (Fig.  1 A), the pep- 
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tide L a 61-80 was nonimmunogenic in BALB/c mice (Fig. 
1  B),  suggesting that  continuous  presentation  of the  self- 
peptide  in BALB/c mice in vivo had resulted in deletion/ 
inactivation of the corresponding autoreactive T  cells. 
We  compared  the  immunogenicity  of the  self-MHC 
class I peptide L d 61-80 in mouse strains differing either by 
their background or MHC genes. As shown in Table 1, A/ 
J  mice, which express the same MHC  haplotype as B10.A 
mice (H-2  ~) but with different background genes, mounted 
vigorous T  cell responses to the self-peptide L d 61-80.  On 
the  other hand,  B10.D2  mice that display the  same back- 
ground  as  B10.A  mice  (B10),  but  distinct  MHC  allelic 
forms  (H-2a),  failed  to  respond  to  the  peptide  L a 61-80. 
Furthermore,  the peptide  L d 61-80 was nonimmunogenic 
in two other H-2  a mice, BALB/c and DBA/2, differing in 
their  background  genes.  The  self-peptide  L a  61-80  was 
therefore  cryptic  in  H-2  ~ mice  while  it  was  consistently 
dominant  in  all  H-2  d  strains,  regardless  of  their  back- 
ground. We conclude that the phenotype of the self-pep- 
tide  L d 61-80,  whether  cryptic or dominant,  is  associated 
with genes located in the MHC locus. 
In  addition,  the  following  results  provided  direct  evi- 
dence  that  BALB/c  APCs  continuously present  the  self- 
peptide  L a 61-80 in association with MHC  class  II mole- 
cules: (a) The peptide L d 61-80 was immunogenic in dm2 
mutant  mice,  a  strain  that  does  not  express  the  L d MHC 
class  I  antigen  (Fig.  1  C).  This  result  demonstrated  that, 
when  seen  as  a  foreign  antigen,  the  peptide  L  d  61-80 
bound to H-2  d class II molecules  (E  d) with sufficient affin- 
ity to ehcit in vivo T  cell responses.  (b) The peptide L d 61- 
80  bound  with  high  affinity  to  E a  class  II  molecules,  as 
shown by its capacity to competitively inhibit the response 
of the  Ea-restricted  T  cell  hybridoma  1E1  to  its  specific 
peptide,  k  repressor  12-26  (Fig.  2  B).  Furthermore,  the 
peptide  L a 61-80 bound equally well to E k class  II mole- 
cules (Fig. 2 A), showing that differential binding to E d and 
E k was not responsible for L a 61-80 phenotype. 
We then investigated the presentation of the self-peptide 
L d 61-80 in  (B10.A  ￿  B10.D2)  F1  mice,  expressing both 
nontolerant  H-2  ~ and tolerant  H-2  d MHC  haplotypes.  F1 
mice were immunized with the peptide L a 61-80, and their 
T  cell  responses  were  determined  after in vitro  challenge 
with the priming peptide.  As shown in Fig.  1 D, the self- 
peptide  L d 61-80  was  found immunogenic  and  therefore 
cryptic in  hybrid  F1  mice.  Contrary  to  our  expectations, 
the  presentation  of the  L d 61-80 peptide  by E k molecules 
was not restored. 
We conclude that the self-peptide L d 61-80 is not natu- 
rally  presented  in  vivo  (cryptic  and  immunogenic)  in 
B10.A mice,  while  it is  efficiendy processed and continu- 
ously  presented  (dominant  and  tolerogenic)  in  BALB/c 
mice. The phenotype of the self-peptide L d 61-80, whether 
cryptic or dominant, therefore does not represent an intrin- 
sic property of this peptide.  It does however,  suggest that 
selection  of the  self-peptide  L  d 61-80  for presentation  to 
autoimmune  T  cells  is  determined  by factors  encoded in 
the MHC  locus that control the processing of L a self-pro- 
tein by APCs. 120000 
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Figure  1.  T  cell  proliferative  re- 
sponses to L  d 61-80 self-peptide  in dif- 
ferent mouse  strains.  Results  are  ex- 
pressed  as  cpm  recorded  with 
lymphoid cells from mice immunized 
with L  d 61-80 peptide.  Lymph node 
cells from B10.A (A) and BALB/c (B) 
mice  restimulated  in  vitro  with  the 
immunizing L  a peptide (0) or a con- 
trol HEL peptide (￿9  The data shown 
here are representative of five separate 
experiments, each including three  to 
five  mice  tested  individually.  The 
background values (cells without anti- 
gens)  ranged  from  3,540  to  5,910 
cpm. BALB/c mice immunized in the 
same  assay with control antigen HEL 
mounted strong proliferative  responses 
to  HEL  105-120  peptide  (95,610  + 
5,200  cpm). (C) Results are expressed 
as cpm recorded with lymph node (cir- 
cles)  and  spleen  (squares) cells  from 
BALB/c  (dashed lines) and  BALB/c- 
din2  (solid lines) mice  restimulated in 
vitro with the immunizing L  a peptide. 
The data  shown here are  representa- 
tive  of  three  experiments  in  which 
three mice of each group were tested 
individually.  No  T  cell  responses 
could be  detected  after restimulation 
of lymph node cells with an irrelevant 
HEL peptide. The background values 
ranged from 2,710 to 3,640 cpm.  (D) 
Results are expressed as cpm recorded with lymph node cells from B10.A (A), B10.D2 (17), and (B10.A ￿  B10.D2) F1 (0) mice challenged in vitro with 
the immunizing L  d peptide.  The background values ranged from 1,850 to 4,870 cpm. 
MHC  Locus of H-2  a Mice Encodes a Factor That Prevents the 
Presentation of the L d 61-80 Peptide.  The Ea-restricted CD4 + 
T  cell line P69.2  (dm2 anti-L  d 61-80) was shown to prolif- 
erate and secrete IL-2 when  incubated with BALB/c  APCs 
in the absence of exogenously added peptide  (Fig.  3  B).  In 
contrast, addition ofpeptide L d 61-80 was required to stim- 
ulate P69.2 T  cell line in the presence of din2 APCs.  Simi- 
lar in vitro  studies  were  conducted  on  the B10.A-derived 
B10.A-P11.2  CD4 +  T  cell line, which recognizes L a 61-80 
peptide  associated  with  E k  MHC  class  II  molecules.  As 
shown  in  Fig.  3  A,  the B10.A-P11.2  cell line  was  stimu- 
lated by syngeneic APCs only when  the L a 61-80 self-pep- 
tide was  added  to  the culture.  This indicated that, in con- 
trast to BALB/c  APCs, B10.A splenocytes did not naturally 
process  the peptide  L d  61-80  efficiently enough  to  stimu- 
late autoreactive T  cells. Taken together, these results show 
that in contrast to their B10.A counterparts, BALB/c  APCs 
regularly  processed  L ~ 61-80  and  efficiendy  presented  the 
self-peptide to autoreactive T  cells. 
In vitro studies have revealed that, in contrast to the pa- 
Table  1.  The Peptide L d 61-80 Is Immunogenic in H-2  ~, but Not H-2  d Mice 
L d 61-80"  HEL 
Haplotype  Strain  Medium*  L d 61-80  Medium  HEL 
H-2  a  B10.D2  3,253  +  1,324  4,810  -+ 890  1,615  _+ 299  89,905  -+ 5,426 
BALB/c  4,228  •  1,033  4,734  +  392  5,034  +  2,945  177,104  -+ 5,128 
DBA/2  2,357  +  865  4,515  +-  1,263  ND  ND 
H-2 a  B10.A  4,104  ~  737  72,442  -  11,921  2,232  _+ 690  104,082  +  6,112 
A/J  4,078  +  986  96,048  +  7,472  3,790  +  1,140  128,634  +  9,111 
*Mice were immunized either with the peptide L  a 61-80 or HEL. 
*Lymph node cells from primed mice were restimulated in vitro either with the immunizing L a peptide or HEL. 
Results are expressed as cpm. The data are representative of three separate  experiments, each including three mice tested individually. The values 
that are significantly over the background counts +  SD are underlined. 
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Figure 2.  L  a 61-80 peptide competi- 
tively inhibits the E  k- and Ea-restricted 
responses ofT cell hybridomas to their 
specific peptides. The following T  cell 
hybridomas were tested in these inhibi- 
tion assays: AOIT.13.1, specific for the 
HEL peptide 85-96 in association with 
I-E  k (A);  and  1E1,  specific for the k 
repressor peptide  12-26 in association 
with I-E  d (B).  Serial concentrations of 
the  following peptides were tested: L d 
61-80  (0)  in  A  and  B;  the  known 
binder peptides  ([]):  HEL  1-17  in A 
and HEL 105-120 in B; and the non- 
binder negative control peptides  (A): 
P4 in A  and L d 61-75  in B.  The re- 
sponses  of  the  T  cell  hybridomas 
AOIT.13.1  to  pHEL  85-96  and  1E1 
to  k  repressor  p12-26  ranged  from 
75,800 to 85,350 and from 38,420 to 
46,990  cpm,  respectively.  Results are 
expressed as percentages of inhibition, 
i.e.,  100X  cpm obtained with specific 
peptide  +  competitor  peptides/cpm 
obtained with specific peptides. 
rental  B10.D2  APCs,  (B10.A  ￿  B10.D2)  F1  splenocytes 
could  not  mediate  the  proliferation  of the  Ed-restricted 
anti-L  a  61-80  T  cell  line  in  the  absence  of exogenously 
added  peptide  (Fig.  3  C).  These  results  showed  that  F1 
APCs could not spontaneously process and present the self- 
peptide  L a 61-80 either in association with E k or even E d 
class II molecules. This indicated that the presence of genes 
located in the MHC  locus of H-2  a mice had impaired L a 
61-80 peptide presentation. 
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1-1-2  k and 1-1-2  d MHC Class II-restricted  T  Cells Recognize  a 
Similar Determinant on the Self-Peptide L d 61-80.  It was pos- 
sible that H-2  a-- and H-2k-restricted T  cell responses were 
directed towards distinct determinants  on the long 20-mer 
L a 61-80.  In recent work, we mapped the T  cell determi- 
nant  recognized by H-2  k class  II-restricted T  cells  on the 
peptide L a 61-80. We showed that T  cells from L a 61-80- 
primed B10.A mice were specific for a determinant located 
in the middle area of the molecule whose core region (resi- 
dues  shared  by all  immunogenic peptides)  contained  resi- 
dues 66-74 (27).  Here,  we examined the fine structure  of 
the determinant  recognized in vivo by T  cells on the pep- 
tide  L d 61-80  presented  in  association  with  H-2  d MHC 
class  II  molecules,  dm2  mice  were  immunized  with  the 
peptide L d 61-80 and were challenged in vitro with a series 
of overlapping 12 mers that progressed along the L d 61-80 
sequence by single residue steps.  As shown in Fig. 4, dm2 
lymph node T  cells responded to a series of five consecu- 
tive  peptides  describing a  determinant  whose  core region 
was 69-76. We conclude that after immunization of B10.A 
and din2  mice with  the self-peptide  L d 61-80,  both H-2  k 
and H-2  a class  II-restricted T  cell responses were directed 
to a similar determinant on the self-peptide. 
The Self-Antigen  L a Is Expressed at Similar Levels in  Tolerant 
and Nontolerant  Mice.  Several reports indicate that the ex- 
tent ofT cell tolerance to self-determinants often correlates 
with quantitative expression of the self-protein (28, 29). To 
test  this  possibility,  we  compared  the  quantity  of L  d ex- 
Figure 3.  BALB/c APCs continuously process and present the self-pep- 
tide L d 61-80,  but not B10.A and (B10.A  ￿  B10.D2)  APCs. Different 
APCs were tested for their abihty to induce the proliferation of the anti- 
L d 61-80 T  cell lines B10.A-P11.2 (A)  and dm2-P69.2 (B) either in the 
absence of exogenously added peptide  (open  bars) or in the presence of 
their specific peptide  L  a 61-80  (solid  bars) or of a  control HEL peptide 
(dashed bars). The results are representative of three separate experiments. 
No  spontaneous proliferation  of a  control  BALB/c  anti-HEL  105-120 
peptide T  cell line was observed under the same experimental conditions 
(data not shown). (C) Different APCs expressing Aa/E  a class II molecules 
were tested for their ability to induce the proliferation of the Ea-restricted 
anti-L  a 61-80 T  cell line dm2-P69.2 either in the absence of exogenously 
added peptide (open  bars) or in the presence of the peptide L  a 61-80 (solid 
bars). B10.A APCs were used as control APCs. 
1485  Fedoseyeva et al. Figure 4.  The proliferative response of BALB/c-dm2 lymph node cells 
to overlapping L  d MHC peptides after immunization with the peptide L  d 
61-80.  Results are expressed as cpm obtained with in vivo L  a 61-80- 
primed BALB/c-dm2  spleen cells restimulated in vitro with  a series of 
MHC  L  a singly overlapping peptides (12  mers). The peptide  number 
shown at the bottom of each panel corresponds to the position of the 
amino-terminal residue of the peptide in the MHC class I sequence. The 
average non-MHC peptide background responses of six to eight wells -+ 
SD were 1,220 +  610 cpm. 
pressed at both messenger RNA  and surface protein levels 
in tolerant (BALB/c, B10.D2)  versus nontolerant  (B10.A, 
A/J) mice. The level of expression of L a mRNA  in tolerant 
and nontolerant mice was identical as determined using an 
La-specific probe  (30)  in a  quantitative RNAse protection 
assay (data not shown). Next, we used an anti-L  d mAb (30- 
5-7)  (26)  to  compare  the  level of L d protein  cell surface 
expression  in  L d  61-80-tolerant  and  -nontolerant  mice. 
The  30-5-7  mAb  was  fluoresceinated and  used  in  direct 
binding  assays  to  detect  the  surface  expression  of L  d  by 
cytofluorometry. As shown in Fig. 5, BALB/c splenocytes 
expressed significant levels of L  d surface  antigen,  whereas 
no  L a protein was detected after exposure of control din2 
(La-deficient) cells to  30.5.7  mAb.  No  quantitative differ- 
ences  in  the  expression  of L d  could be  detected on  both 
spleen and thymus cells of tolerant (BALB/c) and nontoler- 
ant (A/J) mouse strains tested. Similar results were obtained 
with  B10.D2  and B10.A  mice  (data not  shown).  Collec- 
tively, these results show that similar amounts ofL  a mRNA 
and protein are expressed in both L d 61-80-tolerant and - 
nontolerant mice. We therefore conclude that low expres- 
sion of the autoantigen does not account for the crypticity 
of its determinant L a 61-80 in H-2  a mice. 
Mapping of the MHC Locus Region That Controls the MHC 
Class II-restricted  Presentation of the Self-Peptide  L  a 61-80. 
To identify the region of the MHC  locus that contains the 
gene(s)  involved in the processing and presentation of the 
self-peptide L d 61-80,  we  analyzed the  T  cell response to 
this  peptide  in  a  series  of H-2  recombinant  strains.  As 
shown  in Table 2,  the peptide L d 61-80  represents a  self- 
component for all the mice selected in this study since they 
either  express  the  L  d class  I  molecule  or  the  L  q molecule 
0  5e  100  15e  2~0  2~0  0  ~0  100  150  200 
0  ~  100  1~  200  2~ 
Figure 5.  Flow cytometry analysis  of L  d cell surface expression in differ- 
ent mouse strains. Both spleen and thymus cells from A/J, BALB/c, and 
Ld-deficient BALB/c-dm2  mice  were  stained with  FITC-conjugated 
anti-L  d mAbs, 30.5.7 at saturating concentrations and analyzed by flow 
cytometry (solid  profiles). Open profiles were obtained after staining of the 
same cells  with a nonspecific, isotype-matched mAb. 
whose sequence is identical to L a for residues 61-80. L a 61- 
80  self-peptide  was  found  immunogenic  in  B10.AKM 
mice  (Table  2).  Nontolerant  B10.A  and  B10.AKM  mice 
differ from tolerant B10.D2 mice in the portion of the H-2 
region that  is centromeric  to  the  D  gene,  suggesting that 
the MHC  gene(s) that govern(s) self-peptide L a 61-80 pro- 
cessing is located in  this  region  (Table  2).  On  the  other 
hand,  the  L a  61-80  self-peptide was  cryptic in  A.TL  and 
B10.MBR, mice while it was dominant in the parental H-2  s 
and H-2  b mice. Although unlikely, the absence of E  mole- 
cules could have  contributed to  the  nonresponder pheno- 
type in the parental strains. A.TL and B10.MBR  mice dif- 
fer from A/J and B10.AKM mice, respectively, at the H-2 
K  locus (Table 2),  thus  excluding the involvement of this 
area in the processing ofL  d 61-80 peptide. It is noteworthy 
that  A.TL,  B10.D2,  and  BALB/c  mice  share  Qal,  Qa2, 
and Tla alleles, thus ruhng out the contribution of this re- 
gion to L d 61-80 phenotype. Together, these results suggest 
that the region of the MHC  locus of H-2  ~ mice flanked by 
1486  MHC-encoded Factor Governs Self-peptide Processing and T Cell Tolerance Table 2.  Mapping of the 1-1-2 Region Gene(s)  That Control(s)  the Presentation  of L a 61-80 
Strain  H-2  K  A  E  L  D  Medium  L  d 61-80 
BALB/c  d  d  d  d  d  d  2,410  _+ 380  2,890  _+ 450 
BALB/c din2  din2  d  d  d  d  2,740  -  1,520  36,120  _+ 4,660 
B10.D2  d  d  d  d  d  d  6,120  -+ 320  5,410  -+ 910 
DBA/2  d  d  d  d  d  d  2,130  -+ 380  3,870  -+ 820 
B10.A  a  k  k  k  d  d  1,220  +  210  98,630  _  5,140 
A/J  a  k  k  k  d  d  1,720  +  440  72,140  +  2,710 
A.TL  tl  s  k  k  d  d  9,210  +  2,990  88,220  +  3,110 
BI0.AKM  m  k  k  k  q  q  6,330  -+ 990  63,620  +  4,150 
B10.MBR  bql  b  k  k  q  q  1,100  +  280  14,130  +  2,680 
Results are expressed as cpm recorded with lymph node cells from different  H-2 recombinant mouse strains immunized with the peptide L  d 61-80. 
Lymph node cells from primed mice were tested for [3H]thymidine  incorporation after in vitro restimulation with the immunizing L  a 61-80 peptide 
or in the absence ofpeptides. The values that are significandy  over the background counts -+ SD are underlined. 
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Figure 6.  The selfMHC class I peptide L  d 61-80 is nonimmunogenic in 
syngeneic B10.A(5tL) mice. Results  are expressed as cpm recorded with 
lymph node cells from B10.A(5R)  mice immunized with the peptide  L  d 
61-80 (dashed lines) or the HEL control antigen  (solid lines) and restimu- 
lated in vitro with different doses of the L  a peptide (￿9  or a control HEL 
peptide ([2]). The data shown here are representative  of five mice tested 
individually. The background  values (cells without antigens) ranged from 
2,980 to 7,450 cpm. 
the  two  class  I  genes  K  and  D  contains  the  gene(s)  whose 
product(s)  prevent(s)  the processing and presentation  of the 
self-peptide L a 61-80  to T  cells. 
To further constrict the location of the gene(s)  involved 
in the presentation  ofL d 61-80,  we then examined the im- 
munogenicity  of the  self-peptide  in  B10.A(5IL)  H-2  re- 
combinant  mice.  This  strain  was  of particular  interest  be- 
cause although the telomeric portion of their MHC  locus is 
common  with other H-2 a mice, it has an additional recom- 
bination site located in the class  II Ebb3 gene  (referred to as 
E b)  (see Fig. 8).  As shown in Fig.  6,  no T  cell proliferation 
was  detected  after immunization  of B10.A(51L)  mice with 
the  peptide  L a  61-80.  Importantly,  in  contrast  to  B10.A 
APCs, B10.A(5R)  splenocytes could stimulate  the prolifer- 
ation  of the Ek-restricted  B10.A  anti-L  a  61-80  T  cell line 
B10.A-P11.2  in the absence  of an externally added peptide 
(Fig.  7).  C57BL/6  (H-2  b)  and  (C57BL/6  ￿  BALB/K)  F1, 
(H-2  b  X  H-2 k)  F1  APCs  expressing  A b  and  E b,  did  not 
stimulate B 10.A-P11.2,  thus excluding the hypothesis of an 
alloreactive response  (data not shown).  Taken together,  the 
lack  of immunogenicity  of L d  61-80  and  its  continuous 
presentation  at  the  surface  of APCs  show  that  L d  61-80 
represents a dominant self-peptide in B10.A(5R.)  mice. 
Figure 7.  B10.A(5R)  APCs present spontaneously the self- 
peptide L  a 61-80  to the T  cell line B10.A-P11.2.  Different 
APCs expressing Ak/E  k class II molecules (irradiated spleno- 
cytes from [B10.A ￿  B10.D2] F1,  A/J, and B10.A[5R]  mice) 
were tested for their ability to induce the proliferation  of the 
Ek-restricted anti-L  d 61-80  T  cell line, B10.A-P11.2,  either 
in the absence of exogenously added peptide  (solid  bars) or in 
the presence  of their specific peptide  L  a 61-80  (shaded bars). 
B10.D2 APCs were used as control APCs. 
1487  Fedoseyeva et al. Figure  8.  Schematic picture of the 
murine MHC class II region including 
the  recombination  regions  of  the 
mouse strains used in this study. Let- 
ters  flanking  the  "recombination 
bars" indicate the  MHC  haplotypes. 
The  arrows indicate the  direction oi 
gene transcription. 
We conclude that the gene(s) responsible for the pheno- 
type of the peptide L  d 61-80 must reside centromeric of the 
E~3  gene  and  telomeric  of the  K  locus.  Furthermore,  the 
observation that L  d 61-80 was dominant in B10.A(5P,.) and 
cryptic in B10.MBR  allowed us to refine  the mapping of 
the  gene(s)  controlling L  a processing to a  region  of N170 
kb  delimited  by  the  intrarecombinational  points  in  these 
two mouse strains (Fig. 8). 
Discussion 
Recent  studies  have  revealed  that  certain  self-peptides 
(cryptic  self)  do  not  reach  the  threshold  of presentation 
that ensures tolerance induction of developing T  cells  (21, 
22).  Meanwhile,  there  is increasing  evidence that  circum- 
stances which lead to the presentation of cryptic self-deter- 
minants in adults result in the initiation  of an autoimmune 
process  (27,  31,  32).  It  is  therefore  crucial  to  determine 
which factors control the in vivo processing and presenta- 
tion  of self-antigens.  In  this  paper,  the  self-MHC  class  I 
peptide  L  a 61-80 was used as a model antigen to elucidate 
the  mechanisms  that  govern  the  presentation  in  vivo  of 
self-peptides for T  cell tolerance induction. 
The self-peptide L d 61-80 was previously reported to be 
immunogenic in syngeneic B10.A mice while here we ob- 
served that it could not induce any in vivo T  cell responses 
in  BALB/c  mice.  We  have  accumulated  much  evidence 
that associates lack of tolerance in B10.A mice to L  d 61-80 
with poor or incomplete processing of this self-peptide.  In 
this  report we show that,  in  contrast to B10.A APCs,  the 
self-peptide  L  a 61-80 was naturally processed and continu- 
ously presented in association with MHC class II by BALB/c 
APCs;  a  phenomenon  that  ensured  the  deletion/inactiva- 
tion  of  L  d  61-80-reactive  T  cells  during  development. 
Therefore,  the  cryptic  phenotype  of L  d 61-80  we  previ- 
ously reported in B10.A mice does not represent an intrin- 
sic property of this self-peptide as it is dominant in another 
mouse strain, BALB/c. 
The quantity of self-protein available for presentation  to 
autoimmune  T  cells  plays  a  critical  role  in  the  process  of 
tolerance  induction  to  self-determinants  present  on  this 
protein (28, 29). Here, we showed that APCs derived from 
tolerant  and  nontolerant  mouse  strains  expressed  similar 
amounts of the L  a self-antigen at both n~NA  and protein 
levels. It was, however, possible that the presentation of the 
L  a 61-80 peptide was rather dependent on the extracellular 
level of L d protein.  Supporting this hypothesis,  Stockinger 
et  al.  showed  that  T  cell  tolerance  induction  to  peptides 
derived from the fifth component of the complement (C5) 
was merely dependent  on the  presence  of the  self-protein 
in mouse serum (33).  Here,  two lines of evidence indicate 
that circulating L  d protein  does not contribute  to the pre- 
sentation of the peptide L d 61-80 by APCs: (a) Recent evi- 
dence  has  been  provided  that  L  a  61-80  peptide  is  exclu- 
sively processed from intracellular  L  a protein  (24);  (b)  No 
correlation  between  L  a  protein  serum  levels  in  H-2  ~ and 
H-2  d mice and tolerance  to the  self-peptide  L  d 61-80 was 
found (data not shown).  Therefore,  defective presentation 
ofL  d 61-80 in B10.A mice does not result from insufficient 
expression  of the  self-protein,  but  rather  from the  B10.A 
APC's inability to process this self-peptide. 
Analyses  of the  autologous  peptides  bound  to  MHC 
molecules,  as  well  as  determination  of the  molecular  and 
cellular  events involved in antigen processing,  have begun 
to shed light on the mechanisms by which determinants  on 
self-protein are selected for presentation to T  cells.  Recent 
studies using genetically engineered antigen processing-de- 
ficient mice showed the  contribution  of different process- 
ing cofactors to antigen presentation in vivo and suggested 
their  involvement  in  the  acquisition  of T  cell  repertoire 
during development  (34, 35).  However, it remains unclear 
whether allelic polymorphism of the MHC genes encoding 
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cell  repertoire  of normal  mice.  Here,  we  observed  that 
tolerogenicity or  immunogenicity  of the  self-peptide  L  a 
61-80 was a result of differential processing of the self-L  d 
protein in  different mouse strains.  This finding gave us a 
unique opportunity to investigate the contribution of anti- 
gen processing to in vivo T cell tolerance induction in nor- 
mal mice. 
The results presented in this paper indicate that continu- 
ous presentation  of L  a 61-80 peptide by APCs  results  in 
tolerance induction of autoreactive T  cells in BALB/c and 
other H-2  a mice. Interestingly, Loss et al. showed that in- 
tracellular, endogenous, L  d protein represented the unique 
source of self-antigen for continuous processing and pre- 
sentation of the peptide L  a 61-80 by BALB/c APCs  (24). 
This study demonstrated sole involvement of the endoge- 
nous processing pathway in the presentation of L  d 61-80, 
by MHC class II molecules. Together with our results,  this 
indicates that self-peptides processed from intracellular self- 
proteins play an important role in the elimination/inactiva- 
tion of class II-restricted CD4 + developing autoreactive T 
cells. 
MHC class II-restricted presentation ofL  d 61-80 peptide 
from internally synthesized L  a protein segregates from both 
exogenous  and  endogenous  presentation  pathways  (24). 
We therefore hypothesized that either class I or class II pro- 
cessing-associated cofactors could play a role in this "non- 
classical"  antigen  processing pathway.  Here,  we  showed 
that  class II presentation  of the  self-peptide L  a 61-80  for 
tolerance induction of corresponding CD4 + autoreactive T 
cells  was  controlled by gene(s)  which  maps  to  a  170-kb 
portion of the class II region of the MHC locus. Ma and 
Mb genes located in this class II region of MHC locus have 
recently been shown to play an important role in class II- 
restricted  processing.  H-2M  molecules  presumably  pro- 
mote antigen presentation by "freeing" MHC class II pep- 
tide-binding  grooves from  Ii  peptides  in  the  endosomes 
thus  allowing  the  binding  of other  antigen  peptides  to 
MHC  class  II  molecules  (17,  18).  Alternatively,  the  fac- 
tor(s)  involved in L  d 61-80 processing mediates its function 
by disrupting the presentation of the peptide. H-2M mole- 
cules and the L  a 61-80 processing-associated factor, there- 
fore,  seem  to  be  distinct.  Another molecule,  the  Ii,  also 
contributes to the selection of class II-restricted peptides by 
targeting class II molecules to selected endosomal subcom- 
partments (15).  However, Ii is encoded outside the MHC 
locus, and a class II-restricted L  a 61-80-specific T  cell hy- 
bridoma  could be  stimulated  in  the  presence of both  Ii- 
positive and -negative APCs (24). We conclude that Ii does 
not control the presentation of the L  a peptide. 
Among the genes associated with MHC class I process- 
ing, TAP genes are unhkely to be responsible for the phe- 
notype ofL  d 61-80. First,  L  d 61-80 presentation by class II 
molecules  does  not  require  a  functional  TAP-1  protein 
(24).  Second, although limited allehc  polymorphism in the 
mouse transporter genes has been found, it does not seem 
to have a major impact on the selection of the pool of pep- 
tides  available  for presentation  (36,  37).  Alternatively, the 
LMP-7 subunit of the proteasome, despite its documented 
involvement in the class I processing pathway, could repre- 
sent a possible candidate for regulating the presentation of 
L d 61-80.  Supporting this view, H-2  k and H-2  a mice ex- 
press  different LMP-7 alleles  (38,  39).  The LMP-7 allelic 
form expressed by H-2  a,  but not H-2  d mice, by cleaving 
the L d molecule at a particular site could destroy the L  d 61- 
80  determinant  and  therefore prevent its  presentation  in 
MHC class II context to autoreactive thymic T  cells. Work 
to address this possibility is in progress in our laboratory. 
The lack of spontaneous presentation of the self-peptide 
L  a 61-80 in H-2  a, but not H-2  a, mice results in incomplete 
tolerance induction of corresponding autoreactive T  cells. 
Our results show that  a  factor encoded within  a  170-kb 
portion of the  H-2  a,  but not H-2  a,  MHC  locus prevents 
the presentation of the  self-peptide L  a 61-80.  This factor 
presumably mediates its function by disrupting the process- 
ing of the antigen peptide. It is possible that this processing 
factor cleaves L  a protein within  the  sequence 61-80  thus 
destroying the determinant. Another alternative is that this 
factor cleaves L  a protein outside the sequence 61-80. This 
would  create  another  determinant  that  cannot  bind  to 
MHC class II molecules or that could trigger another set of 
T  cells. Finally, this factor could mediate its effect by bind- 
ing L  a 61-80 peptide, thus preventing its  association with 
E k MHC  class II  restriction  elements.  It is  important  to 
note that B10.A APCs do not apparently have a major de- 
fect in antigen processing since they can present a large va- 
riety of endogenously and exogenously processed peptides 
of self- and foreign origin at their surface. Allelic variation 
of processing factors may control the selection of certain of 
self-peptides thus contributing to the acquisition of the T 
cell repertoire in a given strain. 
In conclusion, we have shown that while tolerance in- 
duction of CD4 + T  cells is generally attributed to exoge- 
nous  processing and  presentation  of circulating  self-pro- 
teins,  endogenously  processed  self-peptides  presented  in 
association with MHC class II molecules also contribute to 
the selection of developing CD4 + T cells in the thymus. In 
addition, we observed that MHC class II-restricted presen- 
tation of the endogenously processed self-peptide L  a 61-80 
for T  cell tolerance induction is controlled by a factor en- 
coded within a 170-kb portion of the class II region of the 
MHC  locus.  Apparently,  this factor mediates its  function 
by preventing the presentation of the self-peptide in H-2  a 
but not H-2  a mice and therefore seems to segregate from 
previously described antigen processing cofactors. This sug- 
gests that allelic polymorphism in antigen processing cofac- 
tor genes, by contributing to the selection of self-peptides 
available  for  presentation  by  self-MHC  molecules,  may 
play an essential  role in tolerance induction and acquisition 
of the T  cell repertoire during ontogeny. Therefore, iden- 
tification of the antigen processing factors and elucidation 
of their functions may be crucial for understanding genetic 
susceptibility  to certain autoimmune diseases and the mecha- 
nisms that initiate self-reactive T  cell responses. 
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